Literature DB >> 10565564

Mycoplasma fermentans-induced inflammatory response of astrocytes: selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10.

R Gallily1, M Kipper-Galperin, T Brenner.   

Abstract

Exposure of primary rat glial cells, mostly astrocytes, to heat-inactivated Mycoplasma fermentans triggers the production of tumor necrosis factor alpha (TNFalpha) nitric oxide (NO) and prostaglandin E2 (PGE2). To attenuate the production of these proinflammatory mediators, four agents: aminoguanidine, pentoxifylline, thalidomide and IL-10 were added to astrocyte cultures. Aminoguanidine (1 and 3 mM), an inhibitor of inducible nitric oxide synthase (iNOS), suppressed the production of the three mediators. TNFalpha was the most sensitive to thalidomide, showing dose-response inhibition at concentrations of 20 microg/ml, 50 microg/ml and 250 microg/ml. PGE2 was affected only by concentrations of 50 microg/ml and 250 microg/ml, whereas NO responded solely to the highest amount of this inhibitor. The cytokine IL-10, at 10 U and 50 U, inhibited only TNFalpha production. Our results imply that selective suppression of proinflammatory mediators by various agents may prove feasible for amelioration of central nervous system inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565564     DOI: 10.1023/a:1020234321879

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  Identification of Mycoplasma incognitus infection in patients with AIDS: an immunohistochemical, in situ hybridization and ultrastructural study.

Authors:  S C Lo; M S Dawson; D M Wong; P B Newton; M A Sonoda; W F Engler; R Y Wang; J W Shih; H J Alter; D J Wear
Journal:  Am J Trop Med Hyg       Date:  1989-11       Impact factor: 2.345

Review 2.  Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

Authors:  J D Klausner; V H Freedman; G Kaplan
Journal:  Clin Immunol Immunopathol       Date:  1996-12

Review 3.  The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation.

Authors:  P Shrikant; E N Benveniste
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

4.  Astrocytes, oligodendrocytes, and Schwann cells share a common antigenic determinant that cross-reacts with myelin basic protein: identification with monoclonal antibody.

Authors:  T Brenner; R P Lisak; A Rostami; D E Pleasure; D H Silberberg
Journal:  J Neurosci       Date:  1986-07       Impact factor: 6.167

Review 5.  Mycoplasmas as agents of human disease.

Authors:  G H Cassell; B C Cole
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

Review 6.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

7.  Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages.

Authors:  A Avron; R Gallily
Journal:  J Leukoc Biol       Date:  1995-02       Impact factor: 4.962

8.  Mycoplasma triggering of nitric oxide production by central nervous system glial cells and its inhibition by glucocorticoids.

Authors:  T Brenner; A Yamin; R Gallily
Journal:  Brain Res       Date:  1994-03-28       Impact factor: 3.252

9.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

Authors:  E P Sampaio; E N Sarno; R Galilly; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.